Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Insilico Medicine

An AI-Designed Lung Fibrosis Drug Shifted Aging Clocks in 42 Patients, but Proof of Slower Aging Is Missing

An AI-designed lung drug lowered blood-protein aging clock readings in 42 patients. The study cannot show that it slows aging, and the drug is unapproved.

Experimental AI-Designed Drug Appears To Reverse Biological Age by up to Six Years in Small Human Trial

Experimental AI-Designed Drug Appears To Reverse Biological Age by up to Six Years in Small Human Trial

An AI-designed drug, rentosertib, reduced biological age markers by up to six years in a small study, offering potential insights into treatments for ageing.

International Business Times UK

AI-Designed Rentosertib Raises Eyebrows as It Appears To Make Patients Biologically Younger in Small Trial

AI-Designed Rentosertib Raises Eyebrows as It Appears To Make Patients Biologically Younger in Small Trial

The Rentosertib analysis found a stronger biological-age signal at 30 mg twice daily, while Phase 3 is testing lung function instead

International Business Times UK

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

An AI Drug Company Named a Candidate for Dry Macular Degeneration, and the Target Is Undisclosed

Insilico Medicine nominated ISM9077 for dry AMD and other eye diseases. What a preclinical candidate designation means and what remains undisclosed.

AI drug discovery firm Insilico Medicine signs deal with Korea’s SK Biopharmaceuticals worth $2.5 billion

“We want to be the SpaceX of the pharmaceutical industry,” Alex Zhavoronkov, co-CEO of Insilico Medicine, tells Fortune.

Eli Lilly's $2.75 Billion AI Bet on Anti-Aging Drugs Signals a Major Shift in Pharmaceutical Priorities

Eli Lilly's $2.75B AI deal with Insilico Medicine targets age-related diseases. How AI is transforming longevity drug discovery and what it means for patients.

Eli Lilly Is Bringing AI-Developed Drugs to Market. Should You Buy LLY Stock to Profit?

Eli Lilly has expanded its partnership with Insilico Medicine to bring AI developed medicine into global market.

inkl

Read news from The Economist, FT, and more,
with one subscription

Eli Lilly invests in AI-designed drugs in new deal with Insilico Medicine worth up to €2.39bn

Eli Lilly invests in AI-designed drugs in new deal with Insilico Medicine worth up to €2.39bn

Eli Lilly has partnered with AI biotech Insilico Medicine for exclusive global rights to develop and commercialise medicines designed entirely by artificial intelligence.

AI drug startup Insilico Medicine launches an AI ‘gym’ to help models like GPT and Qwen be good at science

AI drug startup Insilico Medicine launches an AI ‘gym’ to help models like GPT and Qwen be good at science

With the “gym,” Insilico is now targeting other biotech and pharmaceutical companies, offering to train new AI models for them.

Is AI The Key To Beating Cancer? Why Pharma Stocks Are Soaring

Is AI The Key To Beating Cancer? Why Pharma Stocks Are Soaring

Something big is happening in healthcare, as pharma stocks have recently rallied on breakthrough AI developments that could reshape the entire industry.

CEOs share how AI is shaking up the workforce—including an instance of 'robots outcompeting humans in real time'

CEOs share how AI is shaking up the workforce—including an instance of 'robots outcompeting humans in real time'

Chinese startups can develop digital avatars almost as good as human streamers using just a few minutes of footage, noted McKinsey's Rodney Zimmel.

Aging is the inflation of life. An emerging crop of longevity biotech companies needs investment to beat it

Aging is the inflation of life. An emerging crop of longevity biotech companies needs investment to beat it

A new generation of longevity biotech companies with a more conservative approach than their predecessors has emerged—but investment remains constrained.

Only an AI breakthrough can help humans live longer, argues drug developer: 'We need a ChatGPT moment in longevity'

Only an AI breakthrough can help humans live longer, argues drug developer: 'We need a ChatGPT moment in longevity'

Insilico Medicine's founder warns behavioral modification through sleep, diet and exercise has exhausted its potential to extend the average lifespan.

5 astonishing uses of AI happening right now

5 astonishing uses of AI happening right now

From making medical discoveries to changing the way we play games, generative AI is recreating our world

Get all your
news in one place.

100's of premium titles.
One news app.

1

People

Barbara Humpton

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

McKinsey Company

Insilico Medicine

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Macular Degeneration

Pulmonary Fibrosis

Places

416,957 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play